trending Market Intelligence /marketintelligence/en/news-insights/trending/lpxvwCjVws3zRQEQTLN8_A2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Vistin Pharma board proposes dividend

Blog

M&A rebound sparks optimism for near-term deal activity

Blog

Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection

Blog

Banking Essentials Newsletter - February Edition

Blog

Message in a (Word)Cloud


Vistin Pharma board proposes dividend

The Vistin Pharma ASA board proposed an extraordinary dividend of 7 Norwegian kroner per share after completing the sale of its opioids and tablet manufacturing business to TPI Enterprises Ltd.

The company expects a positive net cash effect between 140 million kroner to 150 million kroner, before any transaction costs, from the sale of the assets.

As of Oct. 6, US$1 was equivalent to 8.01 Norwegian kroner.